Second TMR (transmyocardial revascularisation) device wins strong backing from FDA committee
This article was originally published in Clinica
Executive Summary
Eclipse Surgical Technologies last week won backing from an FDA panel for its transmyocardial revascularisation (TMR) system, while receiving nothing but praise on its clinical data.